Patient Surveillance After Cancer Treatment

Przednia okładka
Frank E Johnson, Yoshihiko Maehara, George P Browman, Julie A. Margenthaler, Riccardo A. Audisio, John F Thompson, David Y. Johnson, Craig C. Earle, Katherine S. Virgo
Springer Science & Business Media, 12 mar 2013 - 538

Patient Surveillance After Cancer Treatment covers the history of cancer patient surveillance after curative-intent treatment, the rationale, the methodologies used in the past and at present, the methodologies that will probably emerge in the future, the costs of surveillance, the definitions of various terms used in the field, and how those who are interested in the topic can get more information about it from the internet. The secondary focus of the book is to publicize the need for well-designed, adequately powered randomized clinical trials comparing two (or more) surveillance strategies for each type of cancer.

The audience includes all oncologists, cancer researchers, medical economists and policy makers in government and insurance companies, and finally, interested patients.

This book is part of the Current Clinical Oncology series, which provides cutting-edge knowledge of cancer diagnosis, management, and treatment. World renowned experts share their insights in all the major fields of clinical oncology. From the fundamentals of pathophysiology to the latest developments in experimental and novel therapies, Current Clinical Oncology is an indispensable resource for today’s practicing oncologist.

 

Spis treści

1 Overview
2
2 Introduction to Cancer Surveillance Strategies
9
3 Using Decision Analysis to Model Cancer Surveillance
14
4 Cancer Survivorship Monitoring the LongTerm and Late Effects of Treatment
31
5 Upper Aerodigestive Tract Carcinoma
38
6 Upper Aerodigestive Tract Carcinoma Surveillance Counterpoint Europe
43
7 Upper Aerodigestive Tract Carcinoma Surveillance Counterpoint Japan
46
8 Upper Aerodigestive Tract Carcinoma Surveillance Counterpoint Canada
51
55 Breast Carcinoma Surveillance Counterpoint Europe
281
56 Breast Carcinoma Surveillance Counterpoint Australia
284
57 Breast Carcinoma Surveillance Counterpoint Japan
293
58 Endometrial Carcinoma
296
59 Endometrial Cancer Surveillance Counterpoint USA
301
60 Endometrial Cancer Surveillance Counterpoint USA
305
61 Carcinoma of the Endometrium Surveillance Counterpoint Japan
311
62 Endometrial Carcinoma Surveillance Counterpoint Canada
317

9 Thyroid Papillary Follicular Medullary Hürthle Cell Carcinoma
57
10 Thyroid Papillary Follicular Medullary Hürthle Cell Carcinoma Surveillance Counterpoint Australia
62
11 Thyroid Papillary Follicular Medullary Hürthle Cell Carcinoma Surveillance Counterpoint Japan
69
12 Lung Carcinoma
71
13 Lung Carcinoma Surveillance Counterpoint Australia
75
14 Lung Carcinoma Surveillance Counterpoint Japan
79
15 Lung Carcinoma Surveillance Counterpoint Canada
83
16 Esophagus Carcinoma
93
17 Esophagus Carcinoma Surveillance Counterpoint Australia
96
18 Esophagus Carcinoma Surveillance Counterpoint Japan
101
19 Stomach
107
20 Stomach Carcinoma Surveillance Counterpoint USA
109
21 Stomach Carcinoma Surveillance Counterpoint Japan
113
22 Pancreatic Adenocarcinoma
120
23 Pancreatic Adenocarcinoma Surveillance Counterpoint USA
125
24 Pancreatic Adenocarcinoma Surveillance Counterpoint Europe
128
25 Pancreatic Adenocarcinoma Surveillance Counterpoint Japan
145
26 Pancreatic Adenocarcinoma Surveillance Counterpoint Canada
148
27 Liver and Biliary Tract Carcinoma
153
28 Liver and Biliary Tract Carcinoma Surveillance Counterpoint Europe
156
29 Liver and Biliary Tract Carcinoma Surveillance Counterpoint Australia
159
30 Liver and Biliary Tract Carcinoma Surveillance Counterpoint Japan
165
31 Liver and Biliary Tract Carcinoma Surveillance Counterpoint Canada
168
32 Colon and Rectum Carcinoma
179
33 Colon and Rectum Carcinoma Surveillance Counterpoint USA
185
34 Colon and Rectum Carcinoma Surveillance Counterpoint Australia
188
35 Colon and Rectum Carcinoma Surveillance Counterpoint Japan
195
36 Colon and Rectum Carcinoma Surveillance Counterpoint Canada
199
37 Anal Carcinoma
205
38 Anal Carcinoma Surveillance Counterpoint USA
207
39 Anal Carcinoma Surveillance Counterpoint Australia
215
40 Anal Carcinoma Surveillance Counterpoint Japan
219
41 Anal Carcinoma Surveillance Counterpoint Canada
222
42 Soft Tissue Sarcoma
227
43 Soft Tissue Sarcoma Surveillance Counterpoint USA
231
44 SoftTissue Sarcoma Surveillance Counterpoint Japan
233
45 Soft Tissue Sarcoma Surveillance Counterpoint Canada
235
46 Osteogenic Sarcoma and Dedifferentiated Chondrosarcoma
242
47 Osteogenic Sarcoma and Dedifferentiated Chondrosarcoma Surveillance Counterpoint Japan
247
48 Osteogenic Sarcoma and Dedifferentiated Chondrosarcoma Surveillance Counterpoint Canada
249
49 Cutaneous Melanoma
251
50 Cutaneous Melanoma Surveillance Counterpoint USA
254
51 Cutaneous Melanoma Surveillance Counterpoint Australia
265
52 Cutaneous Melanoma Surveillance Counterpoint Japan
269
53 Breast Carcinoma
273
54 Breast Carcinoma Surveillance Counterpoint USA
277
63 Cervical Carcinoma
323
64 Cervical Carcinoma Surveillance Counterpoint USA
326
65 Cervical Carcinoma Surveillance Counterpoint Japan
335
66 Cervical Carcinoma Surveillance Counterpoint Canada
341
67 Vaginal and Vulvar Carcinoma
348
68 Vaginal and Vulvar Carcinoma Surveillance Counterpoint Japan
353
69 Ovarian Carcinoma
356
70 Ovarian Carcinoma Surveillance Counterpoint USA
361
71 Ovarian Cancer Surveillance Counterpoint Europe
365
72 Ovarian Cancer Surveillance Counterpoint Japan
368
73 Renal Carcinoma
373
74 Renal Carcinoma Surveillance Counterpoint Europe
375
75 Renal Carcinoma Surveillance Counterpoint Japan
380
76 Renal Carcinoma Surveillance Counterpoint Canada
383
77 Urinary Bladder Carcinoma
387
78 Urinary Bladder Carcinoma Surveillance Counterpoint Japan
392
79 Urinary Bladder Carcinoma Surveillance Counterpoint Canada
395
80 Prostate Carcinoma
399
81 Prostate Carcinoma Surveillance Counterpoint USA
403
82 Prostate Cancer Surveillance Counterpoint USA
411
83 Prostate Carcinoma Surveillance Counterpoint Europe
421
84 Prostate Carcinoma Surveillance Counterpoint Japan
423
85 Prostate Carcinoma Surveillance Counterpoint Canada
426
86 Testicle Carcinoma
437
87 Testicle Carcinoma Surveillance Counterpoint USA
442
88 Testicle Carcinoma Surveillance Counterpoint Australia
449
89 Testicle Carcinoma Surveillance Counterpoint Japan
453
90 Lymphoma
456
91 Lymphoma Surveillance Counterpoint USA
461
92 Lymphoma Surveillance Counterpoint Japan
467
93 Lymphoma Following Autologous Stem Cell Transplant
469
94 Lymphoma Following Autologous Stem Cell Transplant Surveillance Counterpoint Japan
471
95 Leukemia
475
96 Leukemia Surveillance Counterpoint USA
478
97 Leukemia Surveillance Counterpoint Japan
485
98 Multiple Myeloma
487
99 Multiple Myeloma Surveillance Counterpoint USA
489
100 Multiple Myeloma Surveillance Counterpoint Australia
493
101 Multiple Myeloma Surveillance Counterpoint Japan
501
102 Multiple Myeloma Surveillance Counterpoint Canada
503
103 Glioma of the Central Nervous System
510
104 Glioma of the Central Nervous System Surveillance Counterpoint Europe
515
105 Glioma of the Central Nervous System Surveillance Counterpoint Australia
517
106 Glioma of the Central Nervous System Surveillance Counterpoint Japan
520
Index
525
Prawa autorskie

Inne wydania - Wyświetl wszystko

Kluczowe wyrazy i wyrażenia

Informacje o autorze (2013)

Dr. Frank E. Johnson, MD

Informacje bibliograficzne